JP2008295921A - Method for alleviating obesity, and health management - Google Patents

Method for alleviating obesity, and health management Download PDF

Info

Publication number
JP2008295921A
JP2008295921A JP2007147753A JP2007147753A JP2008295921A JP 2008295921 A JP2008295921 A JP 2008295921A JP 2007147753 A JP2007147753 A JP 2007147753A JP 2007147753 A JP2007147753 A JP 2007147753A JP 2008295921 A JP2008295921 A JP 2008295921A
Authority
JP
Japan
Prior art keywords
health management
ppm
obesity
hydrogen gas
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007147753A
Other languages
Japanese (ja)
Inventor
Hideo Ueda
秀雄 植田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2007147753A priority Critical patent/JP2008295921A/en
Publication of JP2008295921A publication Critical patent/JP2008295921A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for alleviating obesity, and carrying out health management without deteriorating the health condition while determining whether or not the method is properly carried out. <P>SOLUTION: Acetone and hydrogen concentration in expiration are measured, and the values are monitored, so that specific problems to solve related to lifestyle can be determined. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

本発明は、肥満改善及び健康管理方法に関するものである。   The present invention relates to an obesity improvement and health management method.

最近、メタボリック症候群及びその予備軍と思われる人々が多く、ある統計によると50歳以上の約半分が含まれるとのことである。このメタボリック症候群は単に肥えているというだけでなく、心臓病等種々の疾病の危険性が、そうでない人より非常に高くなることが言われている。   Recently, there are many people who seem to be metabolic syndrome and its reserves, and according to some statistics, about half of those over the age of 50 are included. It is said that this metabolic syndrome is not only fertile, but the risk of various diseases such as heart disease is much higher than those who do not.

よって、メタボリック症候群の人は、自己の健康状態を把握し、且つその状態を改善するよう努める。その第1として、肥満を解消しなければならない。即ち、体重を落とさなければならないのである。   Thus, people with metabolic syndrome try to understand their health condition and improve their condition. First, obesity must be resolved. That is, you have to lose weight.

このダイエットの仕方には、だれもが苦しむことであり、ただ食事による摂取カロリーを減らし、運動などによる消費カロリーを増やすというだけのようであるが、そう単純ではない。まず、そのようことは一般人には理解できないし、やろうという動機に至らない。それとどの程度すればいいのか分からない。   It seems that everyone is suffering from this diet, just reducing the calorie intake from diet and increasing calorie consumption by exercise, but it is not so simple. First of all, it cannot be understood by ordinary people, and it does not lead to motivation to do so. I don't know how much to do with it.

無理な摂取カロリー削減などで急激に体重を落とし過ぎて体調を崩したり、また、その反動でリバウンドしたりすることが多く、その結果体調を崩す破目に陥ったりする。これでは何のためのダイエットか本末転倒である。   In many cases, the body suddenly loses weight due to unreasonable calorie reduction, etc., and it often rebounds due to its reaction, and as a result, it falls into a breach that breaks its physical condition. This is a diet or fall for this end.

そこで、体調を崩さず、且つ自己が行っている方法が適切かどうか判断しながら効率的に体重を落とす方法を提供する。   Therefore, a method of efficiently losing weight while determining whether the method that the person is performing is appropriate is not provided.

このような現状に鑑み、本発明者は鋭意研究の結果本発明肥満改善及び健康管理方法を完成したものであり、その特徴とするところは、呼気中のアセトン及び水素ガス濃度を測定し、それらの数値をモニターすることによって、具体的な生活習慣の改善点を判断することができ、目的を達成する点にある。   In view of such a current situation, the present inventor has completed the obesity improvement and health management method of the present invention as a result of earnest research, and the feature thereof is to measure acetone and hydrogen gas concentrations in exhaled breath, By monitoring these numbers, it is possible to determine specific improvements in lifestyle habits and to achieve the objectives.

まず、本発明において呼気中のアセトン濃度を測定する意義について説明する。人間の体内で、脂肪が代謝される最終過程で、血中にアセト酢酸やアセトン等のケトン体が生成し、アセト酢酸等は臓器で再利用され、アセトンは肺を介して呼気から排出される。よって、呼気中のアセトン濃度を測定することによって体脂肪の燃焼状況を知ることができる。   First, the significance of measuring the acetone concentration in exhaled breath in the present invention will be described. In the final process of metabolism of fat in the human body, ketone bodies such as acetoacetate and acetone are produced in the blood, and acetoacetate is reused in the organs, and acetone is excreted from the breath through the lungs. . Therefore, the burning state of body fat can be known by measuring the acetone concentration in the exhaled breath.

現在の知見では、呼気中のアセトン濃度が1.0ppm以上になると確実に体脂肪が燃焼されていると判断できる。例えば、5ppm程度(1日平均して)ならば、1日あたり100g程度の脂肪が燃焼していると考えられる。ほぼ比例関係にあるため、10ppmならば200gと推測することができる。   According to current knowledge, it can be determined that body fat is surely burned when the concentration of acetone in exhaled air is 1.0 ppm or more. For example, if it is about 5 ppm (averaged daily), it is considered that about 100 g of fat is burned per day. Since it is in a proportional relationship, if it is 10 ppm, it can be estimated that it is 200 g.

体重80kgの人が1ヶ月で6kg減量しようとすると(体脂肪の減量が即体重の減量でなないが、ほぼ近いと言われている)1日200gとなる。よって、呼気中のアセトン濃度が1日平均10ppm程度になるように、日常の生活習慣(摂食量、運動量、およびそのタイミングなど)を変えればよい。   If a person weighing 80 kg tries to lose 6 kg in one month (it is said that body fat loss is not immediate weight loss, but it is almost close), it will be 200 g per day. Therefore, daily lifestyle habits (eating amount, exercise amount, timing thereof, etc.) may be changed so that the acetone concentration in exhaled breath is about 10 ppm on average per day.

1日の平均濃度を知るためには、2時間ごとに1日測定し、それを平均すれば簡単であるが、毎日そのような測定をすることは不可能である。よって、1度そのような比較的頻繁に測定し、平均値を求めておき、その後は、一日の3回の食事前に測定し比例計算する等の方法が実際的である。   In order to know the daily average concentration, it is easy to measure one day every two hours and average it, but such a measurement is impossible every day. Therefore, it is practical to measure the frequency relatively frequently once, obtain an average value, and then measure and proportionally calculate it before three meals a day.

それとも、運動後、食後と決めて毎日何点か測定してもよい。
運動や食後に毎回測定しない限り、食事を大きく変えたり、運動を変えると測定した方がよい。
Or after exercise, you may decide after a meal and measure several points every day.
Unless you measure every time after exercise or meals, it is better to measure if you change your diet or exercise.

このアセトン測定を行いながらダイエットを行うと、自己の運動の方法や程度が適切かどうかが判断できる。よって、アセトン濃度が減少してくれば、運動量を増やせばよい。   When dieting while measuring this acetone, it is possible to determine whether or not the method and degree of self-movement are appropriate. Therefore, if the acetone concentration decreases, the momentum may be increased.

次に本発明において呼気中の水素ガス濃度を測定する意義について説明する。水素ガスはおならの主成分であり、大腸内で食物繊維から菌によって生産されるものである。これが、血中に溶解し前記アセトン同様肺を介して呼気に排出される。   Next, the significance of measuring the concentration of hydrogen gas in exhaled air in the present invention will be described. Hydrogen gas is the main component of fart and is produced by bacteria from dietary fiber in the large intestine. This dissolves in the blood and is discharged into the breath through the lungs like acetone.

この大腸において水素が十分な量産生されるということは、大腸内の種々の菌が活発に活動していることを示しており、これによって下痢や便秘を減少する。   The production of a sufficient amount of hydrogen in the large intestine indicates that various bacteria in the large intestine are actively active, thereby reducing diarrhea and constipation.

また、人間の大腸内には、500種、100兆個以上の細菌がすみついていることが知られている。
我々が摂取した栄養素のうちヒト産生酵素で消化分解、吸収されなかったすべてがその大腸に入る。ここで待ち受けているのがその腸内細菌群(腸内フローラといわれている)である。難消化性炭水化物(多糖類、オリゴ糖類)、タンパク質(高分子アミノ酸)などをエサとしてさまざまな物質を作り出すが、そのうちガス成分では水素ガスが最も多い。
In addition, it is known that 500 types and more than 100 trillion bacteria are living in the human large intestine.
All the nutrients we ingested that were not digested and absorbed by human-produced enzymes enter the large intestine. What is waiting here is the intestinal bacterial group (called intestinal flora). Various materials are produced using foods such as indigestible carbohydrates (polysaccharides, oligosaccharides) and proteins (polymeric amino acids), of which hydrogen gas is the most gas component.

これを簡単な式で表すと、次のようになる。
難消化性成分+嫌気性細菌群→水素ガス+低級脂肪酸+α
ここでαとは、細菌の第三代謝物で、この中にはビタミン、ホルモン、アミノ酸など宿主が有用となる産物。
This can be expressed as a simple formula as follows.
Indigestible component + Anaerobic bacteria group → Hydrogen gas + Lower fatty acid + α
Here, α is a third metabolite of bacteria, among which products such as vitamins, hormones, and amino acids make the host useful.

このことから、大腸に至った難消化性物質の分解には腸内細菌が必須であり、それが正常に活動しているかどうかがわれわれの健康状態に大きな影響を与えるのである。最近、報道やCM等でも、乳酸菌やビフィズス菌の効用が叫ばれているのも、その一端を捉えているものである。   For this reason, enterobacteria are essential for the degradation of indigestible substances that reach the large intestine, and whether or not they are operating normally has a major impact on our health. The fact that the effects of lactic acid bacteria and bifidobacteria have been screamed recently in reports and commercials, etc., captures part of it.

発明者の実験では、便秘症の人10人と、毎日排便のある人10人について呼気中の水素ガス濃度を測定した。便秘群では、2〜4ppm程度で、個人差が少なく、且つ1日の中の変化もほとんどなく最高でも5ppm程度であった。
これに対して、毎日排便のある群では、1日の変化が大きく、8〜25ppmまで変化した。そして、食後に増加するという傾向が見られた。
In the inventor's experiment, the hydrogen gas concentration in exhaled breath was measured for 10 people with constipation and 10 people with defecation every day. In the constipation group, it was about 2 to 4 ppm, there were few individual differences, and there was almost no change during the day, and the maximum was about 5 ppm.
In contrast, in the group with daily defecation, the daily change was large, changing from 8 to 25 ppm. And the tendency to increase after a meal was seen.

このことからも、大腸菌が活発に行動し便秘等のない群は、呼気水穂ガス濃度が高いことがわかる。このことから、逆に水素ガス濃度を測定することによって大腸内環境を見ることができる。   This also indicates that the group with active Escherichia coli and no constipation has a high exhalation water spike gas concentration. On the contrary, the environment in the large intestine can be seen by measuring the hydrogen gas concentration.

定量的には、呼気中の水素ガス濃度が、日内変動幅が、10ppm〜50ppmの場合には、腸内活動が活発であり、正常と考えられる。食後2時間後程度に上昇し、排便、食前に値が低下する。食事内容(バランス、食物繊維量)も適していると考えられる。   Quantitatively, when the concentration of hydrogen gas in the exhalation is within a daily fluctuation range of 10 ppm to 50 ppm, intestinal activity is active and considered normal. It rises about 2 hours after meals and decreases before defecation and before meals. Meal content (balance, dietary fiber content) is also considered appropriate.

更に、呼気中の水素ガス濃度が、100ppm以上の場合には、腸内細菌が異常に増殖しているか、食事バランスが極端に繊維質が多いものに片寄っていると考えられるが、むしろこの状態が長く続くことはないと考えられる。   Furthermore, if the hydrogen gas concentration in the exhaled breath is 100 ppm or more, it is thought that the intestinal bacteria are growing abnormally or that the diet balance is extremely high in fiber. Is not expected to last long.

発明者の実験では、呼気水素ガス濃度の1日平均が、10ppm以下になると腸内細菌が不足するか、食事中の食物繊維が不足するかである。よって、そのような対処をする必要がある。食物繊維を多くとり、また乳酸菌等の多い食物を食べるようにすればよい。   In the inventor's experiment, when the daily average of the breath hydrogen gas concentration is 10 ppm or less, enteric bacteria are insufficient or dietary fiber in the diet is insufficient. Therefore, it is necessary to take such measures. What is necessary is to take a lot of dietary fiber and eat foods with a lot of lactic acid bacteria.

本発明方法は、痩せるためだけを目的に過度の運動をし、食事制限をするというのではなく、腸内バランスも考慮しつつ、生活習慣を判断する点が新しいのである。特に減量という食事制限を伴う行為には、生体バランスを見る指標としての腸内状況を観察しつつ行うことが重要なのである。   The method of the present invention is new in that it does not exercise excessively only for the purpose of thinning and does not restrict diet, but also determines lifestyle habits while taking into account the intestinal balance. It is important to observe the state of the intestines as an index for observing the balance of the living body, particularly for an action that involves dietary restrictions such as weight loss.

本発明肥満改善及び健康管理方法には、次のような健康維持のための効果がある。
1 呼気中のアセトンを測定しているため、体脂肪の燃焼程度が如実に分かり、肥満解消のための日常の生活習慣のリズムの良否が適切に判断できる。
2 呼気中の水素ガスを測定しているため、腸内細菌の活動程度がわかり、腸内環境の良否が分かる。よって、健康維持のための食事内容が適切か等が判断できる。
The obesity improvement and health management method of the present invention has the following effects for health maintenance.
1 Since acetone in breath is measured, the degree of burning of body fat can be clearly understood, and the quality of daily lifestyle rhythms for eliminating obesity can be determined appropriately.
2 Since the hydrogen gas in the exhaled breath is measured, the degree of intestinal bacterial activity is known, and the quality of the intestinal environment is known. Therefore, it can be determined whether the meal content for maintaining health is appropriate.

Claims (5)

呼気中のアセトン及び水素ガス濃度を測定し、それらの数値をモニターすることによって、具体的な生活習慣の改善点を判断することができるのを特徴とする肥満改善及び健康管理方法。   A method for improving obesity and health management, characterized in that by measuring the concentration of acetone and hydrogen gas in exhaled breath and monitoring those values, it is possible to determine specific improvements in lifestyle habits. 呼気中のアセトン濃度が所定値以上になることが、肥満改善の評価基準とするものである請求項1記載の肥満改善及び健康管理方法。   The obesity improvement and health management method according to claim 1, wherein the acetone concentration in exhaled air is equal to or higher than a predetermined value is an evaluation standard for obesity improvement. 該所定値とは、健常者の平均値の2倍、即ち1.0ppmである請求項2記載の肥満改善及び健康管理方法。   3. The obesity improvement and health management method according to claim 2, wherein the predetermined value is twice the average value of healthy subjects, that is, 1.0 ppm. 呼気中の水素ガス濃度が所定値以上であることが、腸内環境が正常と判断するものである請求項1記載の肥満改善及び健康管理方法。   The obesity improvement and health management method according to claim 1, wherein it is determined that the intestinal environment is normal when the hydrogen gas concentration in the exhalation is equal to or higher than a predetermined value. 呼気中の水素ガス濃度が、1日の平均値が10ppm以上、日内変動が±5ppm以上であることが腸内環境が正常と判断するものである請求項1記載の肥満改善及び健康管理方法。
2. The obesity improvement and health management method according to claim 1, wherein the intestinal environment is determined to be normal when the hydrogen gas concentration in the exhalation has an average daily value of 10 ppm or more and a daily fluctuation of ± 5 ppm or more.
JP2007147753A 2007-06-04 2007-06-04 Method for alleviating obesity, and health management Pending JP2008295921A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007147753A JP2008295921A (en) 2007-06-04 2007-06-04 Method for alleviating obesity, and health management

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007147753A JP2008295921A (en) 2007-06-04 2007-06-04 Method for alleviating obesity, and health management

Publications (1)

Publication Number Publication Date
JP2008295921A true JP2008295921A (en) 2008-12-11

Family

ID=40170005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007147753A Pending JP2008295921A (en) 2007-06-04 2007-06-04 Method for alleviating obesity, and health management

Country Status (1)

Country Link
JP (1) JP2008295921A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012011133A (en) * 2010-07-05 2012-01-19 Sharp Corp System for controlling exercise load and method of controlling exercise load
RU2471469C1 (en) * 2011-11-25 2013-01-10 Марина Юрьевна Никотина Method for health improvement in abdominal obesity
WO2013038959A1 (en) * 2011-09-14 2013-03-21 株式会社 エヌ・ティ・ティ・ドコモ Diet support system and diet support method
WO2015033771A1 (en) * 2013-09-05 2015-03-12 株式会社Nttドコモ Exercise load determination method and exercise load determination device
CN104799813A (en) * 2014-01-27 2015-07-29 株式会社百利达 Diet support device and method
DE102015000976A1 (en) 2014-01-27 2015-07-30 Tanita Corporation Apparatus, method and program for detecting a bad body condition
JP2015150153A (en) * 2014-02-13 2015-08-24 株式会社タニタ Apparatus, method and program for evaluating body change
RU2581498C1 (en) * 2014-12-19 2016-04-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации Method for therapeutic exercises for patients with visceral adiposity
JP2017209581A (en) * 2017-09-11 2017-11-30 株式会社タニタ Apparatus, method and program for evaluating body change
KR102106980B1 (en) * 2018-10-25 2020-05-06 연세대학교 산학협력단 Exhaled Hydrogen Analyzer

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012011133A (en) * 2010-07-05 2012-01-19 Sharp Corp System for controlling exercise load and method of controlling exercise load
JPWO2013038959A1 (en) * 2011-09-14 2015-03-26 株式会社Nttドコモ Diet support system and diet support method
WO2013038959A1 (en) * 2011-09-14 2013-03-21 株式会社 エヌ・ティ・ティ・ドコモ Diet support system and diet support method
US9183757B2 (en) 2011-09-14 2015-11-10 Ntt Docomo, Inc. Dieting support system and dieting support method
RU2471469C1 (en) * 2011-11-25 2013-01-10 Марина Юрьевна Никотина Method for health improvement in abdominal obesity
WO2015033771A1 (en) * 2013-09-05 2015-03-12 株式会社Nttドコモ Exercise load determination method and exercise load determination device
JP2015051070A (en) * 2013-09-05 2015-03-19 株式会社Nttドコモ Exercise load determination method and exercise load determination device
CN104799813A (en) * 2014-01-27 2015-07-29 株式会社百利达 Diet support device and method
DE102015000976A1 (en) 2014-01-27 2015-07-30 Tanita Corporation Apparatus, method and program for detecting a bad body condition
US10509025B2 (en) 2014-01-27 2019-12-17 Tanita Corporation Poor physical condition determination device, method, and recording medium stored with program
JP2015150153A (en) * 2014-02-13 2015-08-24 株式会社タニタ Apparatus, method and program for evaluating body change
RU2581498C1 (en) * 2014-12-19 2016-04-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации Method for therapeutic exercises for patients with visceral adiposity
JP2017209581A (en) * 2017-09-11 2017-11-30 株式会社タニタ Apparatus, method and program for evaluating body change
KR102106980B1 (en) * 2018-10-25 2020-05-06 연세대학교 산학협력단 Exhaled Hydrogen Analyzer

Similar Documents

Publication Publication Date Title
JP2008295921A (en) Method for alleviating obesity, and health management
Bauer et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group
Hollis The effect of mastication on food intake, satiety and body weight
Phillips et al. The role of milk-and soy-based protein in support of muscle protein synthesis and muscle protein accretion in young and elderly persons
Hoffman et al. Effect of protein-supplement timing on strength, power, and body-composition changes in resistance-trained men
Bornhorst et al. Gastric digestion in vivo and in vitro: how the structural aspects of food influence the digestion process
Lochs et al. Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics
Deutz et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group
Unick et al. Acute effect of walking on energy intake in overweight/obese women
Gentile et al. Resistant starch and protein intake enhances fat oxidation and feelings of fullness in lean and overweight/obese women
Andersen et al. Carbohydrate-and protein-rich diets in McArdle disease: effects on exercise capacity
AU2016262125B2 (en) Amino acid supplementation
Sangouni et al. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: A double-blind randomised controlled clinical trial
Molan et al. Satiety in rats following blueberry extract consumption induced by appetite-suppressing mechanisms unrelated to in vitro or in vivo antioxidant capacity
Heacock et al. The glycemic, insulinemic, and breath hydrogen responses in humans to a food starch esterified by 1-octenyl succinic anhydride
CN110060778A (en) Using intestinal flora as the health management scheme of target spot
ES2365138T3 (en) COMPOSITION OF DIAGNOSIS FOR TYPE 2 DIABETES AND GLUCOSE INTOLERANCE, AND METHODS OF USE.
Naclerio et al. Effects of protein–carbohydrate supplementation on immunity and resistance training outcomes: a double-blind, randomized, controlled clinical trial
Wróbel et al. Aerobic as well as resistance exercises are good for patients with type 1 diabetes
Marterer et al. 6-week high-intensity interval training (HIIT) of the lower extremities improves VO2max of the upper extremities
Corbin et al. Integrative and quantitative bioenergetics: Design of a study to assess the impact of the gut microbiome on host energy balance
Suryani et al. Type, intensity, and duration of exercise as regulator of gut microbiome profile
da Silveira et al. Is long term creatine and glutamine supplementation effective in enhancing physical performance of military police officers?
Palisin et al. β-Hydroxy-β-methylbutyrate and its use in athletics
Grabitske et al. Laxation and the like: Assessing digestive health